本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Gemini Therapeutics, Inc.

1.35
0.0000
成交量:- -
成交额:8.60万
市值:584.93万
市盈率:-0.13
高:1.35
开:1.35
低:1.35
收:1.35
数据加载中...
2021/02/17

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/02/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/11

重要事件披露

8-K - Current report
2021/02/05

重要事件披露

8-K - Current report
2021/02/05

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/28

企业合并公告

425 - Prospectuses and communications, business combinations
2021/01/28

重要事件披露

8-K - Current report
2021/01/19

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/19

企业合并公告

425 - Prospectuses and communications, business combinations
2021/01/19

重要事件披露

8-K - Current report
2021/01/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals